Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial

Journal of the American Medical Association

Volumn 282, Issue 7, 1999, Pages 637-645

  Ettinger, Bruce ^a   Black, Dennis M ^b   Mitlak, Bruce H ^b   Knickerbocker, Ronald K ^b   Nickelsen, Thomas ^b   Genant, Harry K ^b   Christiansen, Claus ^b   Delmas, Pierre D ^b   Zanchetta, Jose R ^b   Stakkestad, Jacob ^b   Glüer, Claus C ^b   Krueger, Kathryn ^b   Cohen, Fredric J ^b   Eckert, Stephen ^b   Ensrud, Kristine E ^b   Avioli, Louis V ^b   Lips, Paul ^b   Cummings, Steven R ^b  

^a DIVISION OF RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLECALCIFEROL; PLACEBO; RALOXIFENE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SPINE RADIOGRAPHY; THROMBOEMBOLISM; TREATMENT OUTCOME; VERTEBRA FRACTURE;

ADULT; AGED; BONE DENSITY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PIPERIDINES; RALOXIFENE; RISK; SPINAL FRACTURES;

EID: 0033581212     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.7.637     Document Type: Article

References (26)

1. Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 1997;337: 1641-1647.
2. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR, for the Study of Osteoporotic Fractures Research Group. Estrogen replacement therapy and fractures in older women. Ann Intern Med. 1995; 122:9-16.
3. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985;102:319-324.
4. Lufkin KG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 1992;117:1-9.
5. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-1388.
6. Genant HK, Jergas M, Palermo L, et al, for the Study of Osteoporotic Fractures Research Group. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res. 1996;11:984-996.
7. Lu Y, Mathur AK, Blunt BA, et al. Dual x-ray absorptiometry quality control: comparison of visual examination and process-control charts. J Bone Miner Res. 1996;11:626-637.
8. Lu Y, Ye K, Mathur AK, Hui S, Fuerst TP, Genant HK. Comparative calibration without a gold standard. Stat Med. 1997;16:1889-1905.
9. US Food and Drug Administration. National Adverse Drug Reaction Directory: COSTART (Coding Symbols for Thesaurus of Adverse Reaction Terms). Rockville, MD: US Food and Drug Administration; 1970.
10. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res. 1992;7:1389-1398.
11. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem. 1994;40:2022-2025.
12. Black DM, Cummings SR, Karpf DB, et al, for the Fracture Intervention Trial Research Group. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:153-154.
13. Liberman U, Weiss SR, Broll J, et al, for the Alendronate Phase III Osteoporosis Treatment Study Group. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med. 1995;333:1437-1443.
14. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998; 280:2077-2082.
15. Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998;128:793-800.
16. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res. 1996;11:1531-1538.
17. Melton W, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL. Relationship of bone turnover to bone density and fractures. J Bone Miner Res. 1997;12:1083-1091.
18. Chapuy MC, Arlot MC, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ. 1994; 308:1081-1082.
19. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med. 1997;337:670-676.
20. Hulley S, Grady D, Bush T, et al, for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280: 605-613
21. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 1996;348:977-980.
22. Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet. 1996;348:981-983.
23. Perez-Gutthann S, Garcia-Rodriguez LA, Castellsague J, Duque Oliart A. Hormone replacement therapy and risk of venous thromboembolism: a population based case control study. BMJ. 1997;314:796-800.
24. Brooks SE, Yeatts-Peterson M, Baker SP, Reuter KL. Thickened endometrial stripe and/or endometrial fluid as a marker of pathology: fact or fancy? Gynecol Oncol. 1996;63:19-24.
25. Vuento MH, Pirhonen JP, Makinen JT, et al. Endometrial fluid accumulation in asymptomatic postmenopausal women. Ultrasound Obstet Gynecol. 1996;8:37-41.
26. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Baillieres Clin Obstet Gynaecol. 1997;4:31-47.